Investor Braidwell Lp
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Braidwell Lp . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-02-14 13G/A DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 10,162,961 2,393,815
2024-11-14 13G/A DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 9,885,328 10,162,961
2024-02-14 13G/A CRNX / Crinetics Pharmaceuticals, Inc. 3,469,674 0
2024-02-14 13G/A DBVTF / DBV Technologies S.A. 9,382,281 9,885,328
2024-02-14 13G/A DCPH / Deciphera Pharmaceuticals, Inc. 4,599,484 2,385,623
2023-02-14 13G CRNX / Crinetics Pharmaceuticals, Inc. 3,469,674
2023-02-14 13G DBVTF / DBV Technologies S.A. 9,382,281
2023-02-14 13G DCPH / Deciphera Pharmaceuticals, Inc. 4,599,484